These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20422410)

  • 1. Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide.
    Berge G; Eliassen LT; Camilio KA; Bartnes K; Sveinbjørnsson B; Rekdal O
    Cancer Immunol Immunother; 2010 Aug; 59(8):1285-94. PubMed ID: 20422410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315.
    Camilio KA; Berge G; Ravuri CS; Rekdal O; Sveinbjørnsson B
    Cancer Immunol Immunother; 2014 Jun; 63(6):601-13. PubMed ID: 24676901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity.
    Chung Y; Qin H; Kang CY; Kim S; Kwak LW; Dong C
    Blood; 2007 Sep; 110(6):2013-9. PubMed ID: 17581919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine lactoferricin induces caspase-independent apoptosis in human B-lymphoma cells and extends the survival of immune-deficient mice bearing B-lymphoma xenografts.
    Furlong SJ; Mader JS; Hoskin DW
    Exp Mol Pathol; 2010 Jun; 88(3):371-5. PubMed ID: 20171209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of adenoviruses encoding CD40L or IL-2 against B cell lymphoma.
    Meziane el K; Bhattacharyya T; Armstrong AC; Qian C; Hawkins RE; Stern PL; Dermime S
    Int J Cancer; 2004 Oct; 111(6):910-20. PubMed ID: 15300803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma.
    Heier I; Hofgaard PO; Brandtzaeg P; Jahnsen FL; Karlsson M
    Clin Exp Immunol; 2008 May; 152(2):381-7. PubMed ID: 18341610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effect.
    Hu G; Liu Y; Li H; Zhao D; Yang L; Shen J; Hong X; Cao X; Wang Q
    Cell Mol Immunol; 2010 Jul; 7(4):296-305. PubMed ID: 20418899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H; Li F; Gordon JR; Xiang J
    Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
    Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
    J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effector functions of T cells are dependent on in vivo priming and restricted T-cell receptor expression.
    Lüking C; Kronenberger K; Frankenberger B; Nössner E; Röcken M; Mocikat R
    Int J Cancer; 2008 May; 122(10):2280-5. PubMed ID: 18224683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
    Guinn BA; DeBenedette MA; Watts TH; Berinstein NL
    J Immunol; 1999 Apr; 162(8):5003-10. PubMed ID: 10202049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy.
    Houot R; Levy R
    Blood; 2009 Apr; 113(15):3546-52. PubMed ID: 18941113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells.
    Song W; Levy R
    Cancer Res; 2005 Jul; 65(13):5958-64. PubMed ID: 15994975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules.
    Briones J; Timmerman JM; Panicalli DL; Levy R
    J Natl Cancer Inst; 2003 Apr; 95(7):548-55. PubMed ID: 12671023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a hematologic malignancy-selective membranolytic peptide from the antimicrobial core (RRWQWR) of bovine lactoferricin.
    Hilchie AL; Vale R; Zemlak TS; Hoskin DW
    Exp Mol Pathol; 2013 Oct; 95(2):192-8. PubMed ID: 23892223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.
    Casares N; Arribillaga L; Sarobe P; Dotor J; Lopez-Diaz de Cerio A; Melero I; Prieto J; Borrás-Cuesta F; Lasarte JJ
    J Immunol; 2003 Dec; 171(11):5931-9. PubMed ID: 14634104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of antitumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model.
    Siegel S; Wagner A; Schmitz N; Zeis M
    Br J Haematol; 2003 Sep; 122(6):911-4. PubMed ID: 12956760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors.
    Brody JD; Goldstein MJ; Czerwinski DK; Levy R
    Blood; 2009 Jan; 113(1):85-94. PubMed ID: 18812472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific peptide-based vaccines containing the conformationally biased, response-selective C5a agonists EP54 and EP67 protect against aggressive large B cell lymphoma in a syngeneic murine model.
    Kollessery G; Nordgren TM; Mittal AK; Joshi SS; Sanderson SD
    Vaccine; 2011 Aug; 29(35):5904-10. PubMed ID: 21723901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma.
    Palomba ML; Roberts WK; Dao T; Manukian G; Guevara-Patiño JA; Wolchok JD; Scheinberg DA; Houghton AN
    Clin Cancer Res; 2005 Jan; 11(1):370-9. PubMed ID: 15671568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.